These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 27145277)
1. Genetic alteration profiling of patients with resected squamous cell lung carcinomas. Tao D; Han X; Zhang N; Lin D; Wu D; Zhu X; Song W; Shi Y Oncotarget; 2016 Jun; 7(24):36590-36601. PubMed ID: 27145277 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival. Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751 [TBL] [Abstract][Full Text] [Related]
3. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine. Yang JW; Choi YL Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745 [TBL] [Abstract][Full Text] [Related]
4. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms. Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer. Inoue Y; Yoshimura K; Mori K; Kurabe N; Kahyo T; Mori H; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H Oncotarget; 2016 May; 7(22):32113-28. PubMed ID: 27050074 [TBL] [Abstract][Full Text] [Related]
6. Aligning digital CD8 Conde E; Caminoa A; Dominguez C; Calles A; Walter S; Angulo B; Sánchez E; Alonso M; Jimenez L; Madrigal L; Hernando F; Sanz-Ortega J; Jimenez B; Garrido P; Paz-Ares L; de Castro J; Hernandez S; Lopez-Rios F Histopathology; 2018 Jan; 72(2):270-284. PubMed ID: 28815764 [TBL] [Abstract][Full Text] [Related]
7. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics. Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211 [TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria. Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808 [TBL] [Abstract][Full Text] [Related]
9. Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer. Saigi M; McLeer-Florin A; Pros E; Nadal E; Brambilla E; Sanchez-Cespedes M Clin Transl Oncol; 2018 Jul; 20(7):881-888. PubMed ID: 29139039 [TBL] [Abstract][Full Text] [Related]
10. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer. Flockerzi FA; Roggia C; Langer F; Holleczek B; Bohle RM Virchows Arch; 2018 May; 472(5):759-769. PubMed ID: 29270870 [TBL] [Abstract][Full Text] [Related]
11. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases. Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084 [TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative. Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220 [TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases. Paik PK; Shen R; Won H; Rekhtman N; Wang L; Sima CS; Arora A; Seshan V; Ladanyi M; Berger MF; Kris MG Cancer Discov; 2015 Jun; 5(6):610-21. PubMed ID: 25929848 [TBL] [Abstract][Full Text] [Related]
14. PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer. Ikeda S; Okamoto T; Okano S; Umemoto Y; Tagawa T; Morodomi Y; Kohno M; Shimamatsu S; Kitahara H; Suzuki Y; Fujishita T; Maehara Y J Thorac Oncol; 2016 Jan; 11(1):62-71. PubMed ID: 26762740 [TBL] [Abstract][Full Text] [Related]
16. Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lung. Qiong Z; Na WY; Bo W; Zhu Z; Ling P; Bo MH; Min TY; Lei Z; Na HD; Bo Z; Fang LJ; Seng ZS Lung Cancer; 2015 Feb; 87(2):117-21. PubMed ID: 25488863 [TBL] [Abstract][Full Text] [Related]
17. Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients. Das BR; Bhaumik S; Ahmad F; Mandsaurwala A; Satam H Pathol Oncol Res; 2015 Jul; 21(3):675-87. PubMed ID: 25637496 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and Survival Analysis of Japanese Patients with Resected Non-Small-Cell Lung Cancer Harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA Gene Amplification. Inoue Y; Matsuura S; Kurabe N; Kahyo T; Mori H; Kawase A; Karayama M; Inui N; Funai K; Shinmura K; Suda T; Sugimura H J Thorac Oncol; 2015 Nov; 10(11):1590-600. PubMed ID: 26536195 [TBL] [Abstract][Full Text] [Related]